Vanberra Signal

DynamX Medical

Curated by Signal

Provider of a biopsy screening medical device targeting cancer and other diseases

Overview

DynamX Medical, formerly known as BeamLine Diagnostics, is a developer of biopsy screening devices for point-of-care diagnosing of cancer and other diseases in healthy as well as pre-cancer/cancer patients. The patent-pending technology uses infrared spectroscopy, biological information, machine learning and artificial intelligence to provide information from biological samples. The company's imaging solutions are provided through their products - DynamX-Bx (using tissue samples), DynamX-Cs (using cell smears from cheek) and DynamX-Aq (using biofluids). The flagship product - DynamX-Bx along with its DynamX software integrates with existing clinical trials and recognises spectral patterns in healthy and benign samples.

Key facts

Founded
2015

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cannabis-derived nutritional and wellness products

    Health TechnologyUnited Kingdom
  • Online platform for the purchase of customized invisible dental braces

    Health TechnologyUnited Kingdom
  • AI-based brain health diagnosis tool for providers

    Health TechnologyLondon, United Kingdom

About DynamX Medical

What does DynamX Medical do?

DynamX Medical, formerly known as BeamLine Diagnostics, is a developer of biopsy screening devices for point-of-care diagnosing of cancer and other diseases in healthy as well as pre-cancer/cancer patients.

Where is DynamX Medical headquartered?

DynamX Medical is headquartered in Didcot, United Kingdom.

When was DynamX Medical founded?

DynamX Medical was founded in 2015.

Which sector is DynamX Medical in?

DynamX Medical operates in Health Technology.

Who are DynamX Medical's competitors?

Companies similar to DynamX Medical include Rochanna UK, Self Braces, and Cognetivity.